Silexion Therapeutics Corp (SLXN)
Nasdaq · Biological Products, (No Diagnostic Substances) · Inc. E9
What they're doing
Between 2026-06-21 and 2026-09-19, public records show 2 signals for Silexion Therapeutics Corp. Most notable: 2026-07-31: Filed 8-K disclosing director or officer change; 2026-08-13: Filed 8-K disclosing material agreement. Federal contract obligations over the last 24 months total $0. This summary was assembled automatically from SEC EDGAR, USAspending.gov, U.S. Senate lobbying disclosures and Wikimedia pageview counts.
Generated 2026-09-19 from public records.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-04 | Shirvan Mitchell | officer | A | 6,000 | 0 | $0 |
| 2026-06-04 | Horenshtein Hadar Mirit | officer | A | 7,500 | 0 | $0 |
| 2026-06-04 | Hadar Ilan | director | A | 10,000 | 0 | $0 |
| 2026-03-26 | Shirvan Mitchell | officer | S | 22,818 | 1.36 | $31,032 |
| 2026-02-20 | Noy Shlomo | director | A | 9,091 | 0 | $0 |
| 2026-02-20 | Alon Ruth | director | A | 9,091 | 0 | $0 |
| 2026-02-20 | Shirvan Mitchell | officer | A | 49,726 | 0 | $0 |
| 2026-02-20 | Horenshtein Hadar Mirit | officer | A | 49,726 | 0 | $0 |
| 2026-02-20 | Hadar Ilan | director | A | 64,350 | 0 | $0 |
| 2026-02-20 | Abramov Dror Yosef | director | A | 9,091 | 0 | $0 |
| 2026-02-20 | Peled Amnon | director | A | 7,576 | 0 | $0 |
| 2026-02-20 | Lushi Avner | director | A | 9,091 | 0 | $0 |
| 2025-09-15 | Moringa Sponsor, LP | ten percent owner | A | 450,000 | 4 | $1,800,000 |
| 2025-08-07 | Moringa Sponsor, LP | ten percent owner | J | 5,550 | 0 | $0 |
| 2025-02-09 | Abramov Dror Yosef | director | A | 794 | 0 | $0 |
| 2025-02-09 | Alon Ruth | director | A | 794 | 0 | $0 |
| 2025-02-09 | Noy Shlomo | director | A | 1,587 | 0 | $0 |
| 2025-02-09 | Lushi Avner | director | A | 1,587 | 0 | $0 |
| 2025-02-09 | Peled Amnon | director | A | 661 | 0 | $0 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.
Recent filings
- 2026-09-16 DEFA14A
- 2026-09-09 DEFA14A
- 2026-08-24 DEF 14A
- 2026-08-21 8-K
- 2026-08-19 SCHEDULE 13D/A
- 2026-08-18 SCHEDULE 13G
- 2026-08-14 PRE 14A
- 2026-08-14 10-Q
- 2026-08-14 8-K
- 2026-08-13 8-K
- 2026-08-13 8-K
- 2026-08-13 424B4
- 2026-08-13 SCHEDULE 13G/A
- 2026-08-11 EFFECT
- 2026-08-10 S-1/A
- 2026-08-10 8-K
- 2026-08-07 S-1
- 2026-08-04 8-K
- 2026-08-03 8-K
- 2026-07-31 8-K